Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy
- 30 September 1991
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 105 (1), 61-66
- https://doi.org/10.1016/0022-510x(91)90119-r
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- HTLV-I associated myelopathy in an identical twinThe Lancet, 1990
- Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusionAnnals of Neurology, 1990
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- Increased replication of HTLV‐I in HTLV‐I–associated myelopathyAnnals of Neurology, 1989
- Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from JapanInternational Journal of Cancer, 1988
- Activated t‐lymphocytes with polyclonal gammopathy in patients with human t‐lymphotropic virus type i—associated myelopathyAnnals of Neurology, 1988
- The role of HTLV-I in tropical spastic paraparesis in jamaicaAnnals of Neurology, 1988
- HLA study of Japanese patients with Crutzfeldt-Jakob disease: Significant association with HLA-DQw3Annals of Neurology, 1986
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985